Biotech

All Articles

Rivus' stage 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the customers of its fat-busting, muscle-sparing medi...

Ovid stops preclinical job, IV plan after soticlestat stop working

.Ovid Therapy currently exposed last month that it was actually trimming back its own headcount as t...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has opened a $700 million R&ampD facility in the Boston Seaport, increasing its RNA and a...

Boundless Biography creates 'small' discharges five months after $100M IPO

.Only five months after getting a $one hundred thousand IPO, Vast Bio is currently laying off some e...

Halda's $126M will progress 'secure and also kill' growth medications

.The first stages of oncology R&ampD aren't short of appealing brand new methods, and also Halda The...

Lykos 'remorses' certainly not divulging research study violations along with author

.Psychopharmacology has actually taken three articles regarding midstage medical trial information e...

Analysts go into Avidity's DMD win, uncovering distinctions in data

.Avidity Biosciences pleased clients with phase 1/2 information in Duchenne muscular dystrophy (DMD)...

Actinogen's cortisol blocker fails period 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually missed the major endpoint of a phase 2 study in c...

Bivictrix chooses going personal only method to take ADC into clinic

.Antibody-drug conjugates (ADCs) have been at the facility of many a billion-dollar biobuck licensin...

TPG bests up funds to $580M for expenditures throughout life sciences

.Possession manager TPG, which has actually sustained biotechs including Sionna Therapies as well as...